Cargando…
Peptide-Based Bioconjugates and Therapeutics for Targeted Anticancer Therapy
With rapidly growing knowledge in bioinformatics related to peptides and proteins, amino acid-based drug-design strategies have recently gained importance in pharmaceutics. In the past, peptide-based biomedicines were not widely used due to the associated severe physiological problems, such as low s...
Autores principales: | Yang, Seong-Bin, Banik, Nipa, Han, Bomin, Lee, Dong-Nyeong, Park, Jooho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320687/ https://www.ncbi.nlm.nih.gov/pubmed/35890274 http://dx.doi.org/10.3390/pharmaceutics14071378 |
Ejemplares similares
-
Development of a Peptide-Based Nano-Sized Cathepsin B Inhibitor for Anticancer Therapy
por: Park, So-Hyeon, et al.
Publicado: (2023) -
Heparin and Its Derivatives: Challenges and Advances in Therapeutic Biomolecules
por: Banik, Nipa, et al.
Publicado: (2021) -
Synthesis of Lasalocid-Based Bioconjugates and Evaluation
of Their Anticancer Activity
por: Antoszczak, Michał, et al.
Publicado: (2022) -
Bromopyridazinedione-mediated protein and peptide bioconjugation
por: Chudasama, Vijay, et al.
Publicado: (2011) -
Palladium–peptide oxidative addition complexes for bioconjugation
por: Rojas, Anthony J., et al.
Publicado: (2022)